Teladoc, Inc. (TDOC)’s Stock Is Buy After Making 52-Week High

May 17, 2018 - By Alfred Lee

Teladoc, Inc. (NYSE:TDOC) Logo

The stock of Teladoc, Inc. (NYSE:TDOC) hit a new 52-week high and has $50.65 target or 4.00 % above today’s $48.70 share price. The 8 months bullish chart indicates low risk for the $3.04B company. The 1-year high was reported on May, 17 by Barchart.com. If the $50.65 price target is reached, the company will be worth $121.44M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 1.52% or $0.75 during the last trading session, reaching $48.7. About 744,584 shares traded. Teladoc, Inc. (NYSE:TDOC) has risen 60.43% since May 17, 2017 and is uptrending. It has outperformed by 48.88% the S&P500.

Analysts await Teladoc, Inc. (NYSE:TDOC) to report earnings on August, 1. They expect $-0.35 earnings per share, down 25.00 % or $0.07 from last year’s $-0.28 per share. After $-0.39 actual earnings per share reported by Teladoc, Inc. for the previous quarter, Wall Street now forecasts -10.26 % EPS growth.

Teladoc, Inc. (NYSE:TDOC) Ratings Coverage

Among 10 analysts covering Teladoc (NYSE:TDOC), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Teladoc had 18 analyst reports since November 20, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, November 21 by Oppenheimer. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, February 28. Piper Jaffray maintained the shares of TDOC in report on Friday, February 9 with “Buy” rating. KeyBanc Capital Markets maintained it with “Buy” rating and $39.0 target in Sunday, December 3 report. The firm has “Buy” rating by KeyBanc Capital Markets given on Monday, January 8. The firm has “Buy” rating given on Friday, December 8 by Deutsche Bank. The firm earned “Buy” rating on Friday, April 13 by Canaccord Genuity. KeyBanc Capital Markets maintained it with “Overweight” rating and $50 target in Thursday, March 15 report. The firm has “Hold” rating given on Monday, November 20 by Cantor Fitzgerald. Canaccord Genuity maintained it with “Buy” rating and $4300 target in Tuesday, April 3 report.

More notable recent Teladoc, Inc. (NYSE:TDOC) news were published by: Seekingalpha.com which released: “Teladoc’s (TDOC) CEO Jason Gorevic on Q1 2018 Results – Earnings Call Transcript” on May 02, 2018, also Globenewswire.com with their article: “Teladoc to Participate in Upcoming Investor Conferences” published on May 11, 2018, Fool.com published: “Teladoc’s Rising Patient Visits Make for a Good Start to 2018” on May 10, 2018. More interesting news about Teladoc, Inc. (NYSE:TDOC) were released by: Streetinsider.com and their article: “Tiger Global’s 13F Shows New Stake in Twitter (TWTR), Mercado (MELI), Increases Stake in Amazon (AMZN) (more…)” published on May 15, 2018 as well as Profitconfidential.com‘s news article titled: “This Is Why Teladoc Stock Is Primed for Higher Stock Prices” with publication date: May 03, 2018.

Teladoc, Inc. operates a telehealth platform that provides on-demand healthcare services to its members in the United States. The company has market cap of $3.04 billion. The Company’s solution connects clients with its physicians and behavioral health professionals that treat a range of conditions and cases, including acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis; dermatological conditions; anxiety; and smoking cessation. It currently has negative earnings. The firm offers its services through mobile devices, the Internet, video, and phone.

Teladoc, Inc. (NYSE:TDOC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: